Cancer-specific courses

Targeted treatments for breast and ovarian cancer (1 day or 2 half-days)

Level: Intermediate/advanced (Ideal for research nurses, doctors, and other staff working on breast and ovarian cancer trials; requires some prior understanding of cancer biology)

Description:  This course provides an overview of the cellular and genetic makeup of breast and ovarian cancer, along with information on targeted treatments in use and in development for these cancers.
View programme

Targeted treatments for haematological cancers (1 day or 2 half-days)

Level: Intermediate/advanced; advanced/expert (There are two versions of this course, one for doctors and the other for research nurses and other clinical trials staff)

Description: This course introduces the unique cellular and genetic features of haematological cancers. It covers a range of targeted treatment approaches in use and in development for these cancers, including monoclonal antibodies and inhibitors of: FLT3, KIT, JAK2, BTK, NFκB, Bcl-2 and repressor fusion proteins.
View programme

Targeted treatments for urological cancers (1 day or 2 half-days)

Level: Advanced (Ideal for doctors, research nurses and other oncology staff caring for patients with urological cancers)

Description: This course provides a description of the faulty genes and proteins that drive prostate, kidney, bladder and testicular cancer. It also provides an overview of targeted treatment approaches for these diseases, such as hormone therapy, immunotherapy, kinase inhibitors and angiogenesis inhibitors. The relevant science behind each treatment is explained for a non-scientific, non-specialist audience.
Contact Elaine to request the programme

Targeted treatments for lung cancer (half-day or full-day versions available)

Level: Advanced (Ideal for doctors, research nurses and other experienced oncology staff working in lung cancer.)

Description: This course provides a detailed description of the molecular pathology and classification of non-small cell lung cancer, along with information on targeted treatments in use and in development for this disease.

The full day version includes an overview of small cell lung cancer, and a more detailed overview of immunotherapy approaches for lung cancer.
Contact Elaine to request the programme

Targeted treatments for cancers of the digestive system (1 day or 2 half-days)

Level: Advanced (Ideal for research nurses, doctors and other staff working on cancer trials for cancers of the digestive system; requires some prior understanding of cancer biology)

Description: This course provides a sweeping overview of targeted treatments for oesophageal, gastric, colon, rectal, pancreatic and liver cancer. The relevant science behind each treatment is explained for a non-scientific, non-specialist audience.
View programme

Malignant melanoma and beyond: an introduction to targeted treatments and cancer immunotherapy

Level: Intermediate (Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators)

Description: This course describes the recent advances made targeted treatments for cancer, using malignant melanoma as the primary example. Delegates will learn about the faulty genes, pathways and proteins that drive malignant melanoma and other solid tumours, and the mechanism of action of targeted treatments such as B-Raf and MEK inhibitors and immunotherapy.